Benzinga | Apr 23, 2021 09:51AM EDT

RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $232

RBC Capital analyst Frank Morgan maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $205 to $232.